SUKHMINDER SINGH: Open Payments
NPI 1417949371 · POUGHKEEPSIE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,517 in 92 payments from 9 companies in 2025. Trend: 2023 $628 · 2024 $1,065 · 2025 $2,517
Food & beverage: $2,517
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 29 | $946 |
| ABBVIE INC. | 28 | $536 |
| Vanda Pharmaceuticals Inc. | 14 | $419 |
| E.R. Squibb & Sons, L.L.C. | 8 | $236 |
| Alkermes, Inc. | 2 | $149 |
| Supernus Pharmaceuticals, Inc. | 5 | $104 |
| Otsuka America Pharmaceutical, Inc. | 4 | $74 |
| Neurocrine BioSciences, Inc. | 1 | $33 |
| Lundbeck LLC | 1 | $21 |
Products named: CAPLYTA, VRAYLAR, FANAPT, COBENFY, LYBALVI, Qelbree, REXULTI, INGREZZA.
Industry payments across NY — which companies pay providers there.
